快讯!蒙特利尔研究人员发现对抗新冠药物 - 魁省新闻

Ottawa005

知名会员
注册
2009-09-03
消息
650
荣誉分数
295
声望点数
173
魁省省长 called the study "big news" on social networks


Analysis of the study found that colchicine resulted in reductions in hospitalizations by 25 per cent, the need for mechanical ventilation by 50 per cent, and deaths by 44 per cent.
"This is the first hope for patients who have COVID, who are worried and who hope that they will not have complications, there were no tablets that could be taken by mouth and reduce the risks," said Tardif.
Doctor Tardif believes that prescribing the drug could help reduce congestion in hospitals quickly and reduce health-care costs here as elsewhere.
"Our study showed the effectiveness of treatment using colchicine to prevent the phenomenon of the major inflammatory storm and reduce complications related to COVID-19," said Tardif.
Colchicine could be used very quickly to treat people with COVID-19, the researcher says.
"Colchicine is old as it is, we've been treating gout with it for hundreds of years, so it's available in pharmacies, so any doctor tomorrow who reads this can definitely decide to prescribe if he wants."
On Friday evening, Premier Francois Legault called the study "big news" on social networks.
In the spring, Legault said the Colcorona study was one of the largest studies in the world to fight the virus.
The randomized, double-blind, placebo-controlled study was deployed in Canada, the United States, Europe, South America and South Africa.
"It was a double-blind study, meaning neither the patient, nor the team that ran the study including me, knew whether the patient was taking the placebo or the drug, there was just a group, independent from us, which was aware," explained Tardif.
"We are very proud of the work accomplished, it is a clinically convincing result," he said adding that he assembled a spectacular team from all over Quebec including microbiologists, intensivists, statisticians, computer scientists and epidemiologists,

中文相关报道
快讯!蒙特利尔研究人员发现对抗新冠药物-魁省新闻-蒙城华人网-蒙特利尔第一中文网!
重大利好!加拿大科学家发现新冠救命药,已经使用千年,随处可买 - 人在温哥华网 VanPeople.com
这项随机、双盲、安慰剂对照研究在加拿大、美国、欧洲、南美和南非进行。研究小组对经核酸检测证明新冠阳性的4159名患者进行了对照研究,发现口服秋水仙碱片后,可将新冠患者的住院率降低25%、呼吸机使用率降低50%、死亡率降低44%。
Tardif医生认为,秋水仙碱可以立即用于治疗新冠肺炎患者。
昨天晚上接受采访时,他说,“秋水仙碱已经有数百年历史了,我们用它来治疗痛风,可以在药店里买到,所以,明天看到这篇文章的任何医生都可以决定是不是开这个药。”
代表这个由来自魁北克省各地的微生物学家、重症病房医生、统计学家、计算机科学家和流行病学家组成的研究团队,Tardif医生最后自豪地说,“我们对完成的工作感到非常自豪,这是一个令人信服的临床结果。”
 

向问天

日月神教光明左使
VIP
注册
2012-09-04
消息
60,165
荣誉分数
10,925
声望点数
1,273
魁省省长 called the study "big news" on social networks


Analysis of the study found that colchicine resulted in reductions in hospitalizations by 25 per cent, the need for mechanical ventilation by 50 per cent, and deaths by 44 per cent.
"This is the first hope for patients who have COVID, who are worried and who hope that they will not have complications, there were no tablets that could be taken by mouth and reduce the risks," said Tardif.
Doctor Tardif believes that prescribing the drug could help reduce congestion in hospitals quickly and reduce health-care costs here as elsewhere.
"Our study showed the effectiveness of treatment using colchicine to prevent the phenomenon of the major inflammatory storm and reduce complications related to COVID-19," said Tardif.
Colchicine could be used very quickly to treat people with COVID-19, the researcher says.
"Colchicine is old as it is, we've been treating gout with it for hundreds of years, so it's available in pharmacies, so any doctor tomorrow who reads this can definitely decide to prescribe if he wants."
On Friday evening, Premier Francois Legault called the study "big news" on social networks.
In the spring, Legault said the Colcorona study was one of the largest studies in the world to fight the virus.
The randomized, double-blind, placebo-controlled study was deployed in Canada, the United States, Europe, South America and South Africa.
"It was a double-blind study, meaning neither the patient, nor the team that ran the study including me, knew whether the patient was taking the placebo or the drug, there was just a group, independent from us, which was aware," explained Tardif.
"We are very proud of the work accomplished, it is a clinically convincing result," he said adding that he assembled a spectacular team from all over Quebec including microbiologists, intensivists, statisticians, computer scientists and epidemiologists,

中文相关报道
快讯!蒙特利尔研究人员发现对抗新冠药物-魁省新闻-蒙城华人网-蒙特利尔第一中文网!
重大利好!加拿大科学家发现新冠救命药,已经使用千年,随处可买 - 人在温哥华网 VanPeople.com
这项随机、双盲、安慰剂对照研究在加拿大、美国、欧洲、南美和南非进行。研究小组对经核酸检测证明新冠阳性的4159名患者进行了对照研究,发现口服秋水仙碱片后,可将新冠患者的住院率降低25%、呼吸机使用率降低50%、死亡率降低44%。
Tardif医生认为,秋水仙碱可以立即用于治疗新冠肺炎患者。
昨天晚上接受采访时,他说,“秋水仙碱已经有数百年历史了,我们用它来治疗痛风,可以在药店里买到,所以,明天看到这篇文章的任何医生都可以决定是不是开这个药。”
代表这个由来自魁北克省各地的微生物学家、重症病房医生、统计学家、计算机科学家和流行病学家组成的研究团队,Tardif医生最后自豪地说,“我们对完成的工作感到非常自豪,这是一个令人信服的临床结果。”


秋水仙素,生物实验中很常用的让染色体变异的试剂。
 

billwanhua

资深人士
注册
2005-07-07
消息
3,640
荣誉分数
934
声望点数
273
最后编辑:

JClub

初级会员
注册
2019-01-31
消息
174
荣誉分数
121
声望点数
53
太棒了,希望世界各地能发现更多的治疗方法。
 

jy

资深人士
注册
2015-03-14
消息
5,439
荣誉分数
1,102
声望点数
223
7月报道的是可能,这个是大规模验证,不矛盾,就跟hydroxychloroquine一样,开始都说有作用,但是大规模说没有用
的确不一样。
我只是说,没有“突发”,“发现”的感觉了。
 

向问天

日月神教光明左使
VIP
注册
2012-09-04
消息
60,165
荣誉分数
10,925
声望点数
1,273
秋水仙素,生物实验中很常用的让染色体变异的试剂。


看来没有多少人注意“染色体变异”这个词组。
这是极其有害的。
 

nnb

知名会员
注册
2004-08-26
消息
135
荣誉分数
71
声望点数
138

看来没有多少人注意“染色体变异”这个词组。
这是极其有害的。
秋水仙碱是一款抗炎症药物, 最早于公元前1500年从秋番红花中提取出来 ,被用于治疗风湿和肿胀。

其用于痛风治疗也已经有近百年历史,近年来它的抗炎症作用也在心血管疾病治疗中崭露头角,多年临床应用经验提示小剂量秋水仙碱用于抗炎症具有良好的安全性。
 

Ottawa005

知名会员
注册
2009-09-03
消息
650
荣誉分数
295
声望点数
173

m234

⭐安定门箭楼⭐
注册
2005-01-01
消息
4,110
荣誉分数
1,211
声望点数
373
看来没有多少人注意“染色体变异”这个词组。
这是极其有害的。
既然是痛风病人用的药,那他们用药后的副作用应该是统计结果的吧?
 

superlover

青春已经谢幕,可我迟迟不愿退场
VIP
注册
2007-08-08
消息
5,898
荣誉分数
774
声望点数
273
这叫药物 reposition, 我觉得没啥鸟用, 就是利用Colchicine秋水仙碱的免疫抑制作用(以免造成免疫风暴)。 秋水仙碱的确很便宜, 糖皮质激素也很便宜,只是秋水仙人碱没激素那么厉害,但秋水仙人碱起作用的剂量 和中毒剂量差不多, 你说这种药物有多大作用?

和HCQ一样,你自己即使有药,也把不准该吃多少没其致命副作用的风险
 
顶部